Anika Therapeutics Inc banner

Wall St Price Targets

AKP Price Forecast
Based on 5 analysts

+21% Upside
from €11.4 today

Anika Therapeutics Inc (AKP)’s 12-month stock price forecast through November 2027 has a consensus target of €13.79, implying 21% upside. The forecast is based on price targets from 5 Wall Street analysts.

AKP Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for AKP yet.

Anika Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AKP's stock price target?
Price Target
13.79 EUR

According to Wall Street analysts, the average 1-year price target for AKP is 13.79 EUR with a low forecast of 13.65 EUR and a high forecast of 14.2 EUR.

What is the Revenue forecast for Anika Therapeutics Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Anika Therapeutics Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 12%.

Back to Top